An experimental study of construction of EGCG and dextranase loaded nanovesicles and its antibacterial effects on Streptococcus mutans

doi:10.3969/j.issn.1005-4979.2023.02.002

Abstract

Abstract:

Objective: To explore the antibacterial effects of a nanovesicle carrier loaded with epigallocatechin gallate (EGCG) and dextranase on Streptococcus mutans (S.mutans). Methods: The nanovesicles loaded with EGCG and dextranase were fabricated and characterized by transmission electron microscopy (TEM). Drug loading rate was determined by ultraviolet spectrophotometry. Antibacterial properties of nanovesicles against S.mutans were evaluated by antibacterial and bacteriostatic tests. Results: The nanovesicles were successfully constructed, which appeared as uniform spheres under TEM. The particle size was nearly 100 nm, the stability in vitro was fair, and the drug loading rate was 74.06%.The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the synthesized nanovesicles was 24 μg/mL and 32 μg/mL respectively, showing its antibacterial effect on S.mutans. Conclusion: The nanovesicles were successfully constructed and had antibacterial effect on S.mutans.

Key words: nanovesicles, epigallocatechin gallate, dextranase, antibacterial effect

摘要：

目的：探究负载表没食子儿茶素没食子酸酯（epigallocatechin gallate，EGCG）和葡聚糖水解酶的纳米囊泡对变形链球菌(Streptococcus mutans，S.mutans）的抗菌作用。方法：制备负载EGCG和葡聚糖水解酶的纳米囊泡，并利用透射电子显微镜（transmission electron microscope，TEM）对其进行表征，通过紫外吸光度法测定其载药率，通过抑菌及抗菌实验检测其对S.mutans的抗菌效果。结果：负载EGCG和葡聚糖水解酶的纳米囊泡在TEM下为均匀球体，粒径约为100 nm，体外稳定性良好，载药率达74.06%；最小抑菌浓度（minimum inhibitory concentration，MIC）为24 μg/mL，最小杀菌浓度（minimum bactericidal concentration，MBC）为32 μg/mL，显示出抗S.mutans的特性。结论：本实验成功构建了目标纳米囊泡，且其对S.mutans具有抗菌效果。

关键词: 纳米囊泡, 表没食子儿茶素没食子酸酯, 葡聚糖水解酶, 抗菌作用

CLC Number:

R782

ZHAI Zihui, SU Jiansheng. An experimental study of construction of EGCG and dextranase loaded nanovesicles and its antibacterial effects on Streptococcus mutans[J]. 《Journal of Oral and Maxillofacial Surgery》, 2023, 33(2): 71-76.

翟子惠, 苏俭生. 负载EGCG和葡聚糖水解酶的纳米囊泡构建及其对变形链球菌抗菌作用的实验研究[J]. 《口腔颌面外科杂志》, 2023, 33(2): 71-76.

/ / Recommend / Download Citations

URL: https://journal06.magtech.org.cn/Jweb_joms/EN/10.3969/j.issn.1005-4979.2023.02.002

https://journal06.magtech.org.cn/Jweb_joms/EN/Y2023/V33/I2/71

Figures/Tables 5

Figure 1 Nano-characterization of P1

Table 1 Effects of different dosages of P1 on the characteristics of nanovesicles

PBA-PEI/mg	葡聚糖水解酶/mg	EGCG/mg	分散度	粒径/nm
30 30 30 30 30	10.03 20.06 25.08 28.08 30.09	0.74 1.48 1.85 2.07 2.22	0.474 0.663 0.213 0.202 0.515	021.84 067.91 068.04 100.40 147.20

Figure 2 The MTT method determined the absorbance value of different concentrations of P1 solution

Figure 3 Plate colony distribution of different concentrations of P1 solution

Figure 4 Changes of pH value of the medium at concentrations of 0-32 μg/mL P1

References 20

[1]	Lemos JA, Palmer SR, Zeng L, et al. The biology of Streptococcus mutans[J]. Microbiol Spectr, 2019, 7(1): 1-18.
[2]	Cugini C, Shanmugam M, Landge N, et al. Therole of exopolysaccharides in oral biofilms[J]. J Dent Res, 2019, 98(7): 739-745. doi: 10.1177/0022034519845001 pmid: 31009580
[3]	Liu N, Li X, Wang MF, et al. DexA70, the truncated form of a self-produced dextranase, effectively disrupts Streptococcus mutans biofilm[J]. Front Microbiol, 2021, 12: 2274.
[4]	Zhang LL, Liang EJ, Cheng Y, et al. Is combined medication with natural medicine a promising therapy for bacterial biofilm infection?[J]. Biomedecine Pharmacother, 2020, 128: 110184.
[5]	Mi GJ, Shi D, Wang M, et al. Reducing bacterial infections and biofilm formation using nanoparticles and nanostructured antibacterial surfaces[J]. Adv Healthc Mater, 2018, 7(13): 1-23.
[6]	刘崇懿. 苯硼酸修饰的树形高分子用于生物大分子的胞内递送[D]. 上海: 华东师范大学, 2019.
[7]	Grela E, Kozłowska J, Grabowiecka A. Current methodology of MTT assay in bacteria-A review[J]. Acta Histochem, 2018, 120(4): 303-311. doi: S0065-1281(18)30027-8 pmid: 29606555
[8]	Chevalier M, Ranque S, Prêcheur I. Oral fungal-bacterial biofilm models in vitro: A review[J]. Med Mycol, 2018, 56(6): 653-667. doi: 10.1093/mmy/myx111 pmid: 29228383
[9]	McEwen SA, Collignon PJ. Antimicrobial resistance: A one health perspective[J]. Microbiol Spectr, 2018, 6(2):1-26.
[10]	Ferri M, Ranucci E, Romagnoli P, et al. Antimicrobial resistance:A global emerging threat to public health systems[J]. Crit Rev Food Sci Nutr, 2017, 57(13): 2857-2876. doi: 10.1080/10408398.2015.1077192 URL
[11]	Fulaz S, Vitale S, Quinn L, et al. Nanoparticle-biofilm interactions: The role of the EPS matrix[J]. Trends Microbiol, 2019, 27(11): 915-926. doi: S0966-842X(19)30185-4 pmid: 31420126
[12]	Mubeen B, AnsarAN, Rasool R, et al. Nanotechnology as a novel approach in combating microbes providing an alternative to antibiotics[J]. Antibiotics (Basel), 2021, 10(12): 1473.
[13]	Makabenta JMV, Nabawy A, Li CH, et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections[J]. Nat Rev Microbiol, 2021, 19(1): 23-36. doi: 10.1038/s41579-020-0420-1
[14]	Bhattacharjee S. DLS and Zeta potential-what they are and what they are not?[J]. J Control Release, 2016, 235: 337-351. doi: 10.1016/j.jconrel.2016.06.017 URL
[15]	Manciu M, Manciu FS, Ruckenstein E. On the surface tension and Zeta potential of electrolyte solutions[J]. Adv Colloid Interface Sci, 2017, 244: 90-99. doi: 10.1016/j.cis.2016.06.006 URL
[16]	Zaichik S, Steinbring C, Jelkmann M, et al. Zeta potential changing nanoemulsions: Impact of PEG-corona on phosphate cleavage[J]. Int J Pharm, 2020, 581: 119299. doi: 10.1016/j.ijpharm.2020.119299 URL
[17]	Xi YJ, Wang Y, Gao JY, et al. Dual corona vesicles with intrinsic antibacterial and enhanced antibiotic delivery capabilities for effective treatment of biofilm-induced periodontitis[J]. ACS Nano, 2019, 13(12): 13645-13657. doi: 10.1021/acsnano.9b03237 pmid: 31585041
[18]	Kamaly N, Yameen B, Wu J, et al. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release[J]. Chem Rev, 2016, 116(4): 2602-2663. doi: 10.1021/acs.chemrev.5b00346 pmid: 26854975
[19]	Han SL, Abiko Y, Washio J, et al. Green tea-derived epigallocatechin gallate inhibits acid production and promotes the aggregation of Streptococcus mutans and non-mutans Streptococci[J]. Caries Res, 2021, 55(3): 205-214. doi: 10.1159/000515814 URL
[20]	Zhang Q, Ma QZ, Wang Y, et al. Molecular mechanisms of inhibiting glucosyltransferases for biofilm formation in Streptococcus mutans[J]. Int J Oral Sci, 2021, 13(1): 30. doi: 10.1038/s41368-021-00137-1

Please choose a citation manager

Content to export